Grand Pharmaceutical Group Investor Relations Material
Latest events
H1 2025
19 Aug, 2025
H2 2024
19 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Grand Pharmaceutical Group Limited
Access all reports
Grand Pharmaceutical Group Limited is a healthcare company engaged in the research, development, manufacturing, and distribution of pharmaceutical and medical products. The company specializes in prescription drugs, biopharmaceuticals, medical devices, and consumer healthcare products, serving therapeutic areas such as cardiovascular, respiratory, oncology, and ophthalmology. The company is headquartered in Wuhan, China, and its shares are listed on the Hong Kong Stock Exchange (HKEX).
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
512
Country
🇭🇰 Hong Kong